Related Experiment Video
Updated: Feb 15, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
Esther J Y Kim1, Minna-Liisa Anko2, Christoffer Flensberg1
1The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia.
Abstract:
Despite intensive efforts to optimize the process, reprogramming differentiated cells to induced pluripotent stem cells (iPSCs) remains inefficient. The most common combination of transcription factors employed comprises OCT4, KLF4, SOX2, and MYC (OKSM). If MYC is omitted (OKS), reprogramming efficiency is reduced further. Cells must overcome several obstacles to reach the pluripotent state, one of which is apoptosis. To directly determine how extensively apoptosis limits reprogramming, we exploited mouse embryonic fibroblasts (MEFs) lacking the two essential mediators of apoptosis, BAK and BAX. Our results show that reprogramming is enhanced in MEFs deficient in BAK and BAX, but only when MYC is part of the reprogramming cocktail. Thus, the propensity for Myc overexpression to elicit apoptosis creates a significant roadblock to reprogramming under OKSM conditions. Our results suggest that blocking apoptosis during reprogramming may enhance the derivation of iPSCs for research and therapeutic purposes.
Insights
Blocking apoptosis enhances induced pluripotent stem cell (iPSC) generation when using the OKSM factors. This finding reveals that Myc-induced apoptosis is a key barrier to efficient iPSC reprogramming.
Area of Science:
- Cell biology
- Stem cell research
- Molecular biology
Background:
- Induced pluripotent stem cell (iPSC) generation is crucial for regenerative medicine but remains inefficient.
- The combination of OCT4, KLF4, SOX2, and MYC (OKSM) is commonly used for reprogramming.
- Apoptosis, or programmed cell death, is a known obstacle during the reprogramming process.
Purpose of the Study:
- To investigate the role of apoptosis in limiting reprogramming efficiency.
- To determine if inhibiting apoptosis can enhance iPSC generation.
Main Methods:
- Utilized mouse embryonic fibroblasts (MEFs) genetically engineered to lack the apoptosis mediators BAK and BAX.
- Compared reprogramming efficiency with and without MYC in these apoptosis-deficient MEFs.
Main Results:
- Reprogramming efficiency was significantly enhanced in MEFs lacking BAK and BAX, but only when MYC was included in the reprogramming cocktail (OKSM).
- The absence of MYC (OKS) in apoptosis-deficient MEFs did not show the same enhancement, indicating MYC's role in inducing apoptosis.
- Overexpression of MYC was identified as a major contributor to apoptosis during reprogramming.
Conclusions:
- Myc-induced apoptosis presents a significant roadblock to efficient iPSC reprogramming under OKSM conditions.
- Blocking apoptosis pathways, such as those mediated by BAK and BAX, can improve iPSC derivation.
- These findings suggest that targeting apoptosis could be a viable strategy to enhance iPSC generation for research and therapeutic applications.
More Related Videos
Related Concept Videos
Apoptosis
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Introduction to Nuclear Reprogramming
Methods of Nuclear Reprogramming
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

